CF Bankshares Inc (NASDAQ: CFBK) has reported earnings for its third fiscal quarter (ending September 30) of $0.63 versus $0.66 for the same period a year ago — a decline of -5%. For the latest […]
For its third fiscal quarter (ending September 30), The ODP Corporation (NASDAQ: ODP) has reported a 32% increase in E.P.S. from $1.39 a year ago to $1.83 in the current quarter. Relative to the consensus […]
Extremely significant negative changes in SIGA Technologies Inc (NASDAQ: SIGA) investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume. Significant negative changes in SIGA Technologies Inc (NASDAQ: […]
Extremely important positive changes in investment behavior have recently occurred for Ryanair Holdings PLC (NASDAQ: RYAAY): its shorter term price trend turned up, its longer term price trend turned up, the stock’s recent price rise […]
Theravance Biopharma Inc (NASDAQ: TBPH). Extremely significant positive changes in investment behavior have recently occurred: its shorter term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside volume […]
XPEL Inc (NASDAQ: XPEL) has reported earnings for its third fiscal quarter (ending September 30) of $0.49 versus $0.48 for the same period a year ago — an increase of 2%. However, this result fell […]
Travere Therapeutics Inc (NASDAQ: TVTX) stock suffered a major decline of -11.8% on 11/8/23. The shares closed at $6.33. The stock has been extremely weak relative to the market over the last nine months and […]
VistaGen Therapeutics Inc (NASDAQ: VTGN) stock closed at $3.08 on 11/8/23 after a major decline of -11.4%. Relative to the market the stock has been weak over the last nine months and has declined -3.1% […]
For its third fiscal quarter (ending September 30), Computer Task Group Inc (NASDAQ: CTG) has reported a -175% decline in E.P.S. from $0.08 a year ago to $-0.06 in the current quarter. For the latest […]
Amicus Therapeutics Inc (NASDAQ: FOLD) has reported E.P.S. of $-0.07 for its third fiscal quarter (ending September 30) versus $-0.12 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research